ArticleHeliyon2023
Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas.
A C L Mortensen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleHeliyon2023
A C L Mortensen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.